Close

Dynavax (DVAX) to Present New Data for SD-101 in Combination with KEYTRUDA at ASCO

May 16, 2018 5:16 PM EDT Send to a Friend
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that data will be presented from its ongoing Phase 1b/2 study investigating SD-101 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login